EE05750B1 - Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine - Google Patents

Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine

Info

Publication number
EE05750B1
EE05750B1 EEP201500006A EEP201500006A EE05750B1 EE 05750 B1 EE05750 B1 EE 05750B1 EE P201500006 A EEP201500006 A EE P201500006A EE P201500006 A EEP201500006 A EE P201500006A EE 05750 B1 EE05750 B1 EE 05750B1
Authority
EE
Estonia
Prior art keywords
microorganism strain
strain lactobacillus
lactobacillus gasseri
gasseri mcc2
dsm
Prior art date
Application number
EEP201500006A
Other languages
English (en)
Inventor
Tiiu Kullisaar
Mihkel Zilmer
Ene Tammsaar
Andre Veskioja
Epp Songisepp
Kersti Zilmer
Lauri Bobrovski
Kersti Ehrlich
Merle Rätsep
Margus Punab
Maire Vasar
Marika Mikelsaar
Original Assignee
OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus filed Critical OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus
Publication of EE201500006A publication Critical patent/EE201500006A/et
Publication of EE05750B1 publication Critical patent/EE05750B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/22—Working-up of proteins for foodstuffs by texturising
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/208—Fermentation of skim milk or milk and its addition in a small quantity to unfermented skim milk or milk, e.g. cheese milk; Addition of yoghurt to cheese milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/145—Gasseri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Abstract

Leiutis käsitleb mikroorganismi tüve Lactobacillus gasseri MMC2 DSM 23882 ning selle kasutamist antioksüdantse proteolüütilise koostisosana toidutoote või toidulisandi valmistamiseks. Nimetatud mikroorganismi sisaldavad toidutooted ja toidulisandid on hüpoallergeensed, nende tarbimine vähendab piimaallergiat ja eesnäärme healoomulise suurenemisega kaasnevaid alumiste kuseteede ärritussümptomeid, nendega seotud oksüdatiivset stressi ja põletikku.
EEP201500006A 2011-02-25 2011-02-25 Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine EE05750B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP201100012A EE05721B1 (et) 2011-02-25 2011-02-25 Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine

Publications (2)

Publication Number Publication Date
EE201500006A EE201500006A (et) 2015-03-16
EE05750B1 true EE05750B1 (et) 2015-06-15

Family

ID=57759915

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP201100012A EE05721B1 (et) 2011-02-25 2011-02-25 Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EEP201500006A EE05750B1 (et) 2011-02-25 2011-02-25 Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP201100012A EE05721B1 (et) 2011-02-25 2011-02-25 Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine

Country Status (9)

Country Link
US (1) US20140037792A1 (et)
EP (2) EP2966164B1 (et)
JP (1) JP5785275B2 (et)
KR (1) KR101586778B1 (et)
CN (2) CN103649304B (et)
EE (2) EE05721B1 (et)
RS (1) RS54478B1 (et)
RU (1) RU2603059C2 (et)
WO (1) WO2012126481A1 (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101664310B1 (ko) * 2015-02-16 2016-10-10 (주)케비젠 공액리놀레산을 생산하는 락토바실러스 가세리 cbg-c20 균주 및 이의 용도
CN105018379B (zh) * 2015-07-16 2018-12-28 山东凤凰生物有限公司 一株具高抗氧化活性的植物乳杆菌及其应用
IT201700068000A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
MX2020012594A (es) 2018-05-23 2021-04-28 Ko Biolabs Inc Cepa de lactobacillus gasseri kbl697 y uso de la misma.
RU2715565C1 (ru) * 2019-03-12 2020-03-02 Денис Геннадьевич Почерников Способ диагностики нарушений гормонального фона у мужчин
CN110577912B (zh) * 2019-09-24 2022-03-29 华南理工大学 一种格氏乳杆菌及其在制备发酵乳中的应用
CN116004558B (zh) * 2020-11-02 2024-05-07 武汉大学 乙酰转移酶OsG2基因及其编码的蛋白质在调节水稻植株高度方面的应用
CN112402465B (zh) * 2020-12-18 2022-12-30 四川大学华西医院 一种植物乳杆菌n-1在制备预防和/或改善良性前列腺增生的产品及用途
CN113637609A (zh) * 2021-08-17 2021-11-12 大连工业大学 一种降低乳蛋白抗原性的植物乳杆菌
CN115029260B (zh) * 2022-05-09 2023-08-25 江南大学 一种具有抗炎及抗氧化特性的格氏乳杆菌及应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100200A (en) 1870-02-22 skinnek
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
JP3226695B2 (ja) 1994-01-12 2001-11-05 森永乳業株式会社 乳化性及び熱安定性に優れた乳清蛋白質分解物の製造法、並びに該乳清蛋白質分解物を使用した抗アレルギー性調製乳
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
SE510813C2 (sv) 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
BR9914184A (pt) * 1998-10-01 2001-06-19 Probi Ab Redução de fatores de forças oxidativas
IL143632A0 (en) * 1998-12-11 2002-04-21 Urex Biotech Inc Pharmaceutical compositions containing lactobacillus
FI991008A0 (fi) 1999-05-03 1999-05-03 Bioferme Oy Runsaskuituinen viljaemulsio ja menetelmä sen valmistamiseksi
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
NZ511202A (en) 2001-04-19 2002-11-26 New Zealand Dairy Board Savoury-flavoured food product produced in a short time by fermentation of a protein-based medium by at least two different strains of food-grade bacteria
JP4119656B2 (ja) * 2002-02-28 2008-07-16 雪印乳業株式会社 抗酸化剤
DK1485463T3 (da) * 2002-03-21 2008-11-10 Bifodan As Lactobacillus stamme
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
KR20040067161A (ko) 2003-01-21 2004-07-30 (주) 피엘바이오 비뇨기 감염 질환을 예방하거나 억제할 수 있는 유산균과이를 포함하는 기능제품
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
RU2407784C2 (ru) * 2003-12-17 2010-12-27 Н.В. Нютрисиа Пробиотический штамм lactobacillus casei, продуцирующий молочную кислоту, применение штамма для приготовления питательной композиции для лечения или профилактики легочной дисфункции, питательная композиция и способ ее получения, лекарственное средство для лечения или профилактики хронической обструктивной болезни легких у субъекта и применение штамма для приготовления лекарственного средства, контейнер
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
CN101171019B (zh) * 2005-03-03 2012-05-23 株式会社明治 免疫功能调节剂
KR100801556B1 (ko) * 2005-04-04 2008-02-11 대한민국 항산화 활성을 갖는 Ｌａｃｔｏｂａｃｉｌｌｕｓｇａｓｓｅｒｉ ＮＬＲＩ 312
US10428395B2 (en) * 2005-10-11 2019-10-01 Probiotical S.P.A. Method for the preparation of anallergic probiotic bacterial cultures and related use
JP5081242B2 (ja) * 2006-08-04 2012-11-28 バイオニア コーポレイション 人間母乳から分離したプロバイオティック活性、及び体重増加抑制活性を有する乳酸菌
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US20080274162A1 (en) 2007-05-04 2008-11-06 Jeffrey Nessa Method, composition, and delivery mode for treatment of prostatitis and other urogenital infections using a probiotic rectal suppository
PL210465B1 (pl) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
JP2010095465A (ja) * 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
CN101427782B (zh) 2008-11-27 2012-05-30 赵敏 玉米双歧益生菌饮料及其制作方法

Also Published As

Publication number Publication date
EP2678419B1 (en) 2015-09-23
CN103649304A (zh) 2014-03-19
EE201100012A (et) 2012-10-15
RS54478B1 (en) 2016-06-30
RU2603059C2 (ru) 2016-11-20
EE201500006A (et) 2015-03-16
EP2966164A1 (en) 2016-01-13
JP5785275B2 (ja) 2015-09-24
US20140037792A1 (en) 2014-02-06
KR20140020939A (ko) 2014-02-19
WO2012126481A1 (en) 2012-09-27
EP2966164B1 (en) 2017-04-19
JP2014506475A (ja) 2014-03-17
CN105733983A (zh) 2016-07-06
RU2013143134A (ru) 2015-03-27
CN103649304B (zh) 2016-03-23
KR101586778B1 (ko) 2016-02-02
CN105733983B (zh) 2019-09-06
EE05721B1 (et) 2014-08-15
EP2678419A1 (en) 2014-01-01

Similar Documents

Publication Publication Date Title
EE201500006A (et) Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
Ayyash et al. In vitro investigation of bioactivities of solid-state fermented lupin, quinoa and wheat using Lactobacillus spp.
MX2013011626A (es) Efecto antimicrobiano sinergico.
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
NZ729306A (en) Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
WO2011110918A8 (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
AU2010269814A8 (en) Heat resistant probiotic compositions and healthy food comprising them
CY1113187T1 (el) Απομονωμενο στελεχος του μικροοργανισμου lactobacillus plantarum tensia dsm 21380 ως αντιμικροβιακο και αντιυπερτασικο προβιοτικο, τροφιμο και συνθεση που περιλαμβανει τον εν λογω μικροοργανισμο και χρηση του εν λογω μικροοργανισμου για την παρασκευη ενος αντιυπερτασικου φαρμακου και μεδοθος για την καταστολη των παθογονων και των γαλακτοβακιλλων που δεν χρησιμοποιουνται ως ζυμη μεσα σε ενα τροφιμο
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
MX339951B (es) Bacillus subtilis aislado de maiz.
PH12016500271A1 (en) Probiotic for infantile excessive crying
EE05799B1 (et) Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks
MX2015010694A (es) Peptidos funcionales para trastornos de obesidad.
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
MX2010000915A (es) Uso de cuando menos un derivado de oxima de colest-4-en-3-ona como antioxidantes.
BR112014004123A2 (pt) micro-organismos das espécies bacteroides xylanisolvens
GR1008378B (el) Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX355787B (es) Cepas de lactococcus lactis y preparaciones bacterianas de las mismas, para la producción de péptidos bioactivos que tienen efectos antihipertensivos y de disminución de colesterol en mamíferos; productos nutricionales y terapéuticos producidos a partir de los mismos.
MX345948B (es) Uso de cepas mutantes resistentes a la nisina de lactobacilos para reducir la post-acidificación en los productos alimenticios.
WO2012021016A3 (ko) 항암 활성을 갖는 락토바실러스 균주 및 이를 활성성분으로 포함하는 항암 활성 조성물
WO2010000373A8 (en) Oil containing hydroxytyrosol and other biophenols with a beneficial preventive nutritional activity
WO2012062867A8 (de) Unbeladene pegylierte liposomen zur verwendung als arzneimittel zur prophylaxe und therapie von hämorrhagischen und thromboembolischen erkrankungen

Legal Events

Date Code Title Description
HC1A Change of owner name
GB1A Change in the ownership or in the address of the owner